
Keywords: CIS; clinically isolated syndrome; CPS; control preference scale; DMTs; disease modifying therapies; JCV; JC virus; MRI; magnetic resonance imaging; MSDS 3D; Multiple Sclerosis Documentation System 3D; MSIF; Multiple Sclerosis International Federation; NA